FDA issues statement/update on Ozempic NAION risk by March 31, 2025
Mini
5
Ṁ415Mar 31
4%
chance
1D
1W
1M
ALL
Given international scrutiny of Ozempic's potential link to NAION, this market predicts whether the FDA will issue any formal statement or safety update specifically addressing NAION risk for Ozempic users by March 31, 2025. Resolution based on FDA website announcements.
References:
Get
1,000and
1.00
1,0001.00Related questions
Related questions
Will the Ozempic shortage be resolved on December 31st, 2025 according to the FDA?
87% chance
Ozempic approval is revoked or withdrawn before 2031
6% chance
Will Ozempic be ranked within the top three prescribed drugs for diabetes by June 30, 2024?
2% chance
Ozempic will NOT be the leading GLP-1 agonist by total $ US sales by December 31, 2025
42% chance
Will Ozempic be FDA approved for use in type 1 diabetes patients by end of 2024?
7% chance
Will Steve austad regularly try ozempic by EOY 2028
31% chance
Will Pfizer announce a weight loss drug competing with Ozempic and Wygovy before 12/31/2024?
35% chance
Will Ozempic / semaglutide be FDA-approved for Alzheimer's before 2030?
58% chance
Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?
15% chance
Will there be a recall of Wegovy/Ozempic before 2035?
80% chance